Suggested Topics within your search.
Showing 1,281 - 1,300 results of 1,444 for search 'Patient’s Medication Knowledge', query time: 0.10s Refine Results
  1. 1281

    Ambulance quality and outcome measures for general non-conveyed populations (AQUA): A scoping review. by Erik Höglund, Carl Magnusson, Jakob Lederman, Douglas Spangler, Lilian Vloet, Remco Ebben

    Published 2024-01-01
    “…The use of quality- and outcome measures among non-conveyed patients is an understudied phenomenon.<h4>Aim</h4>To identify current quality- and outcome measures for the general population of non-conveyed patients in order to describe major trends and knowledge gaps.…”
    Get full text
    Article
  2. 1282

    Payment models and the sustainability of community pharmacy practice: a qualitative interview study with community pharmacists by Kelly Ann Schmidtke, Terri Warholak

    Published 2025-12-01
    “…The median percentage of patients served on Medicare Part D was 35% (range 24% to 60%). …”
    Get full text
    Article
  3. 1283
  4. 1284
  5. 1285
  6. 1286
  7. 1287
  8. 1288
  9. 1289

    The Effect of Telenursing on Disease Outcomes in People with Type 2 Diabetes Mellitus: A Narrative Review by Mina AkbariRad, Mohsen Dehghani, Masoumeh Sadeghi, Ashkan Torshizian, Nikoo Saeedi, Mehrdad Sarabi, Mahdieh Sahebi, Mohammad Taghi Shakeri

    Published 2023-01-01
    “…Telenursing can effectively supplement healthcare professionals to manage PWT2D. Increasing patientsknowledge about their drugs, insulin administration, and diabetes complications improves self-care behaviors and medical adherence. …”
    Get full text
    Article
  10. 1290
  11. 1291
  12. 1292
  13. 1293
  14. 1294

    Lifestyle Factors in Hypertension Drug Research: Systematic Analysis of Articles in a Leading Cochrane Report by Dan E. Wilson, Tashina Van Vlack, Brendin P. Schievink, Eric B. Doak, Jason S. Shane, Elizabeth Dean

    Published 2014-01-01
    “…This study systematically reviewed the methodology of articles from a recent Cochrane review that had been designed to inform first-line medical treatment of hypertension and was representative of high quality established clinical trials in the field. …”
    Get full text
    Article
  15. 1295

    Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database by Sue Perera, Liyuan Ma, Raj Punwaney, Sulabha Ramachandran

    Published 2018-02-01
    “…We report descriptive data from employees and their families, as covered by employer-sponsored medical insurance. The primary cohort comprised patients with pSS (with ≥1 diagnosis of sicca syndrome prior to January 1, 2013), with continuous enrollment for ≥24 months (January 1, 2012–December 31, 2013). …”
    Get full text
    Article
  16. 1296

    Drug Clues for the Treatment of Fungal Catheter-Related Bloodstream Infection With Antifungal Lock Therapy by Li X, Yu B, Li H, Liu Z, Fu X, Jiao P, Wang L

    Published 2025-01-01
    “…Shandong First Medical University @ Shandong Academy of Medical Sciences, Jinan, 250117, People’s Republic of ChinaCorrespondence: Ping Jiao; Lei Wang, Email jiaopingonlyone@163.com; wanglei1118@sdfmu.edu.cnBackground: Biofilm formation often represents significant challenges in managing of bloodstream infections associated with catheter use.Objective: Antimicrobial lock therapy serves as an adjunctive treatment for catheter-related infections, effectively eradicating or inhibiting biofilm growth.Methods: This review synthesizes the current knowledge on antifungal lock therapy (ALT) targeting clinically common fungi, primarily Candida species, based on both in vitro and in vivo studies (animals and patients) from the past decade.Results: Amphotericin B (AmB) and echinocandins are identified as the most promising antifungal agents for ALT. …”
    Get full text
    Article
  17. 1297
  18. 1298
  19. 1299
  20. 1300